Not available
Quote | Amdocs Limited (NASDAQ:DOX)
Last: | $90.37 |
---|---|
Change Percent: | -0.11% |
Open: | $90 |
Close: | $90.37 |
High: | $90.565 |
Low: | $89.77 |
Volume: | 408,517 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Amdocs Limited (NASDAQ:DOX)
2024-03-24 08:37:16 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-03-21 12:27:07 ET Summary 20 new dividend increases with an average increase of 8.5% and a median of 8% are shared. Companies that regularly raise their dividends perform better; a list of top stocks expected to raise dividends is provided. Analysis of companies with incr...
Message Board Posts | Amdocs Limited (NASDAQ:DOX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $DOX News Article - DOX INVESTORS ACT NOW: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORN | whytestocks | investorshangout | 05/13/2021 6:15:49 PM |
whytestocks: $DOX News Article - Amdocs Ltd (DOX) Q2 2021 Earnings Call Transcript | whytestocks | investorshangout | 05/13/2021 5:15:50 PM |
whytestocks: $DOX News Article - Amdocs Ltd (DOX) Q4 2020 Earnings Call Transcript | whytestocks | investorshangout | 11/11/2020 6:15:47 PM |
News: $DOX Telefónica and Amdocs Agree to Extend | whytestocks | investorshub | 05/16/2019 12:10:40 PM |
Nice | insymbols | investorshub | 05/13/2019 7:45:25 AM |
News, Short Squeeze, Breakout and More Instantly...
Amdocs Limited Company Name:
DOX Stock Symbol:
NASDAQ Market:
Survey of CSP leaders across the US, Europe and Asia found GenAI implementation still in its preliminary stages; challenges include data quality and regulation JERSEY CITY, NJ / ACCESSWIRE / March 21, 2024 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications a...
Amdocs' amAlz platform brings new Generative AI-powered applications to customers faster, enabling them to benefit from the immense potential of GenAI while also providing enterprise-grade security, reliability, and performance Amdocs will be highlighting amAIz and GenAI-powered solutions at...
Using Amdocs' GenAI platform amAIz, and Microsoft Azure OpenAI Service, extended collaboration will include a GenAI lab and center of excellence to accelerate GenAI adoption and development of robust capabilities to the market JERSEY CITY, NJ / ACCESSWIRE / February 26, 2024 / Amdocs (NASDAQ...